相关实验视频

Updated: Jun 4, 2025

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

通过抑制IDO活性和重编程CD8+T细胞反应来设计癌症免疫疗法的细菌

Heng Wang¹, Fang Xu¹, Chenlu Yao¹

¹Laboratory for Biomaterial and Immunoengineering, Institute of Functional Nano and Soft Materials, Soochow University, Suzhou, Jiangsu 215123, China.

Proceedings of the National Academy of Sciences of the United States of America

|December 18, 2024

概括

工程细菌 (L-Trp CB) 抑制瘤中的胺2,3二氧化酶 (IDO),促进CD8+ T细胞的反应. 这种合成生物学方法显示了增强癌症免疫疗法的前景,并减少了副作用.

科学领域:

合成生物学合成生物学
免疫学免疫学免疫学
微生物学微生物学

背景情况:

氧化酶 (IDO) 抑制是抗癌疗法的关键策略.
目前的IDO抑制剂存在临床挑战,限制了它们的应用.
瘤微环境通常会抑制抗瘤免疫反应.

研究的目的:

开发一种新的以细菌为基础的战略,用于IDO抑制和增强癌症免疫疗法.
在瘤模型中研究基因工程高酸盐表达*Clostridium butyricum* (L-Trp CB) 的疗效.

主要方法:

用*Clostridium butyricum*的基因工程来过度表达托.
针对瘤殖民的L-Trp CB的系统管理.
在瘤微环境中分析IDO活性,托芬水平和CD8+T细胞反应.
在小鼠和子模型中评估瘤生长抑制.

主要成果:

L-Trp CB成功地在瘤中定居,并产生丁酸盐,抑制IDO活性.
由L-Trp CB释放的甲基促进了CD8+ T细胞的激活和代谢.
在小鼠和子模型中观察到瘤生长的显著延迟.
在L-Trp CB治疗中,副作用有限.

结论:

基因工程 *Clostridium butyricum* 为癌症免疫治疗提供了一个有前途的合成生物学方法.
这种策略有效地抑制IDO活动,并重新编程瘤微环境以增强CD8+T细胞的反应.
L-Trp CB代表了对多种瘤类型的潜在治疗剂.

关键词:

在 IDO IDO 里面.对于T细胞的反应反应.工程细菌就是工程细菌.合成生物学合成生物学托芬三聚氨酸是什么

更多相关视频

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics

Published on: June 7, 2024

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...